Concomitant Radio-chemotherapy in the Elderly

Inclusion Criteria: * Age ≥ 70 years * Independent patients (based on the score of geriatric frailty: IADL = 0, ADL = 0, no geriatric syndrome, low comorbidity (comorbidity index of Charlson to 3 or 4), depression score 0-1) * Performance Status (ECOG) ≤ 1 * Weight loss \<10% of usual weight in the last 3 months * Life expectancy greater than 12 weeks * Hematologic function: neutrophils\> 1.5 x 10\*\*9 / l, hemoglobin\> 9.5 g / dl, platelets \> 100 x 10\*\*9 / l) * Renal function: creatinine clearance ≥ 50 ml / min calculated by the formula of MDRD * Normal liver function: bilirubin \< Limit of Normal (ULN), SGOT and / or SGPT \<2.5 x UNL * Respiratory Function: FEV ≥ 40% predicted, PaO2 ≥ 60 mm Hg, KCO ≥ 60% predicted * Patient affiliated to a social security regimen or beneficiary of such regimen * Informed consent signed The disease * Pathological anatomy: CBP non-small cell (squamous cell carcinoma, adenocarcinoma, large cell carcinoma, undifferentiated carcinoma) histologically or cytologically proven * Stage IIIAN2 considered inoperable stage IIIB * Presence of at least one measurable target * Delay at least three weeks between surgery and initiation of treatment * No prior treatment with chemotherapy or radiotherapy for lung cancer Exclusion Criteria: * Age \< 70 years * Performance Status (ECOG) ≥ 2 * Hematologic function: neutrophils \<1.5 x 10\*\*9 / l, hemoglobin \<9.5 g / dl, platelets \<100 x 10\*\*9 / l) * Renal function: creatinine clearance \<50 ml / min calculated by the formula of MDRD * Hepatic: bilirubin\> Upper Limit of Normal (ULN), SGOT and / or SGPT\> 2.5 x ULN * Respiratory Function: FEV \<40% predicted, KCO \<60% predicted, PaO2 \<60 mmHg * Peripheral neuropathy grade\> 1 * Unstable cardiac pathology requiring treatment (heart failure, angor of effort, arrhythmia) or previous myocardial infarction older than 12 months * Deafness not paired or deafness requiring major achievement of an audiogram-cons may indicate taking cisplatin * Neurological or psychiatric disorders prohibiting the understanding of the test * Previous history of cancer except basal cell cancer, carcinoma in situ of the cervix treated or any other cancer treated with surgery alone or radiotherapy alone extra-thoracic recurrence-free 5 years * Significant malabsorption syndrome or disease affecting the functioning of the gastrointestinal tract The disease * Pathological anatomy: Bronchioloalveolar carcinoma, neuroendocrine carcinoma, small cell carcinoma * Metastatic disease * Pleural drain * Carcinomatous lymphangitis * Operable Cancer * Previously treated for lung cancer disease: radiotherapy, chemotherapy, hormonal therapy, endobronchial suctioning older less than eight days